Navigate / search

Bioequivalent Drugs: Worth the risk?

Santiago, Chile – August 2012 – as published in BUSiness Chile.  Chile’s pharmaceutical market is worth US$2 billion, but in recent years it has cost patients both their pesos and their trust. The government’s recent decision to certify bioequivalent drugs in Chile aims to increase access for consumers by providing an affordable alternative to branded products. […] Read more